tiprankstipranks
Trending News
More News >
Cranswick plc (GB:CWK)
:CWK
UK Market

Cranswick (CWK) AI Stock Analysis

Compare
35 Followers

Top Page

GB

Cranswick

(LSE:CWK)

Rating:78Outperform
Price Target:
Cranswick's overall stock score of 78 reflects its strong financial performance and positive corporate developments. The strategic growth plans and executive share purchases bolster investor confidence. However, the valuation concerns and technical indicators suggesting potential caution moderate the score.
Positive Factors
Acquisitions
CWK has announced the acquisition of Blakemans, a leading food-service sausage manufacturer for £32m.
Earnings
Cranswick's FY25 PBT of £197.9m has come in ahead of the range endorsed at its CMD in March and consensus.
Licensing
The China export licence has been reinstated after 4 years, enabling shipping from early January.
Negative Factors
Public Relations
CWK shares are -8% following stories in the weekend press about 'cruelty' to pigs in a Lincolnshire farm owned by CWK.
Supply Chain
Supermarkets and Cranswick itself have suspended supplies from Northmoor Farm.

Cranswick (CWK) vs. iShares MSCI United Kingdom ETF (EWC)

Cranswick Business Overview & Revenue Model

Company DescriptionCranswick plc manufactures and supplies food products to grocery retailers, food service sector, and other food producers in the United Kingdom, Continental Europe, and internationally. The company offers fresh pork, gourmet bacon and gammon, fresh and coated chicken, ready to eat chicken, charcuterie, houmous and dips, and olives and antipasti, gourmet sausages, cooked meats, gourmet pastries, and ingredients, as well as cheeses and pasta. It also offers snacks and sharing boxes under the Bodega brand; olives, olive oil, and pulses under the Cypressa brand; Mediterranean foods under the Ramona's Kitchen brand name; and pet food and supplies under the Vitalin and Alpha Feeds, as well as operates export business. The company was incorporated in 1972 and is based in Hessle, the United Kingdom.
How the Company Makes MoneyCranswick makes money by producing and selling a diverse range of fresh and value-added food products, primarily in the pork and poultry categories. The company's revenue streams are predominantly from supplying its products to major UK supermarkets, foodservice providers, and other retailers. Cranswick benefits from long-term supply agreements and partnerships with key customers, which help ensure a stable demand for its products. Additionally, the company invests in its own farming operations and processing facilities to maintain control over quality and costs, thereby enhancing its profitability. Cranswick's commitment to sustainability and innovation further supports its revenue growth by aligning its offerings with consumer trends towards ethically sourced and health-focused products.

Cranswick Financial Statement Overview

Summary
Cranswick's financial performance is strong, with solid revenue growth, improved profitability, and effective cash flow management. The company has a low debt-to-equity ratio and a robust equity base, indicating stability. However, the increase in liabilities warrants monitoring.
Income Statement
85
Very Positive
Cranswick's income statement shows strong revenue growth with an 11.9% increase in the most recent year, which underscores robust market demand. The gross profit margin improved to 14.5%, indicating enhanced cost efficiency. Net profit margin also increased slightly to 4.35%. EBITDA margin stands at a healthy 9.75%, reflecting solid operating performance. Overall, the income statement reveals a positive growth trajectory and profitability improvements.
Balance Sheet
78
Positive
The balance sheet is stable, with a debt-to-equity ratio of 0.14, which suggests a low leverage risk. Return on Equity (ROE) is at 12.4%, showing effective use of shareholder funds to generate profits. The equity ratio remains strong at 65.8%, indicating a solid asset base supported by equity. However, the rising liabilities should be monitored.
Cash Flow
82
Very Positive
Cash flows are robust, with a significant free cash flow growth of nearly 100% year-over-year, reflecting efficient capital management. Operating cash flow to net income ratio is strong at 2.02, indicating healthy cash generation relative to profits. The company demonstrates effective cash flow management, supporting its growth and investment strategies.
Breakdown
TTMMar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Income StatementTotal Revenue
2.68B2.60B2.32B2.01B1.90B1.67B
Gross Profit
401.50M376.90M295.70M276.80M265.70M217.60M
EBIT
185.90M166.90M130.80M136.70M128.10M101.30M
EBITDA
256.20M253.60M220.00M199.00M185.50M155.20M
Net Income Common Stockholders
115.50M113.10M111.40M103.50M92.50M82.70M
Balance SheetCash, Cash Equivalents and Short-Term Investments
27.00M27.00M20.40M200.00K39.90M23.00M
Total Assets
1.38B1.38B1.26B1.14B1.04B995.50M
Total Debt
127.40M127.40M121.70M106.20M131.40M168.40M
Net Debt
100.40M100.40M101.40M106.00M92.40M146.90M
Total Liabilities
472.50M472.50M421.50M373.60M355.00M380.20M
Stockholders Equity
911.50M911.50M842.90M768.90M686.10M614.50M
Cash FlowFree Cash Flow
155.00M127.90M64.10M64.70M109.00M14.60M
Operating Cash Flow
254.70M228.40M149.20M158.40M180.90M115.80M
Investing Cash Flow
-112.40M-123.30M-83.80M-130.90M-81.80M-164.30M
Financing Cash Flow
-161.70M-93.40M-45.30M-66.30M-81.60M49.50M

Cranswick Technical Analysis

Technical Analysis Sentiment
Positive
Last Price5300.00
Price Trends
50DMA
5170.60
Positive
100DMA
5059.05
Positive
200DMA
4987.91
Positive
Market Momentum
MACD
12.45
Positive
RSI
53.69
Neutral
STOCH
34.66
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For GB:CWK, the sentiment is Positive. The current price of 5300 is above the 20-day moving average (MA) of 5294.50, above the 50-day MA of 5170.60, and above the 200-day MA of 4987.91, indicating a bullish trend. The MACD of 12.45 indicates Positive momentum. The RSI at 53.69 is Neutral, neither overbought nor oversold. The STOCH value of 34.66 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for GB:CWK.

Cranswick Peers Comparison

Overall Rating
UnderperformOutperform
Sector (65)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
GBPFD
79
Outperform
£1.72B14.019.02%0.86%5.90%11.24%
GBGNC
78
Outperform
£985.33M18.7512.12%0.88%0.49%14.18%
GBCWK
78
Outperform
£2.82B20.9114.14%0.95%8.74%-8.69%
76
Outperform
£2.38B38.003.39%2.38%-11.03%-2.05%
75
Outperform
£1.24B22.359.10%4.46%4.03%3.21%
GBHFG
72
Outperform
£764.74M19.4512.74%5.84%-0.03%7.88%
65
Neutral
$8.73B15.104.69%4.08%3.64%-2.90%
* Consumer Defensive Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
GB:CWK
Cranswick
5,300.00
932.08
21.34%
GB:HFG
Hilton Food
848.00
-17.60
-2.03%
GB:PFD
Premier Foods
202.00
36.75
22.24%
GB:TATE
Tate & Lyle
528.00
-67.11
-11.28%
GB:GNC
Greencore
223.50
55.71
33.20%
GB:BAKK
Bakkavor Group plc
216.00
78.76
57.39%

Cranswick Corporate Events

Business Operations and Strategy
Cranswick Director Acquires Shares Under Incentive Plan
Neutral
Apr 25, 2025

Cranswick plc announced that Director Christopher Aldersley acquired ordinary shares as ‘Partnership Shares’ under the company’s 2024 Buy As You Earn Share Incentive Plan. This acquisition, part of a regular monthly purchase program, also included the awarding of ‘Matching Shares,’ reflecting the company’s ongoing commitment to aligning management interests with shareholder value.

Spark’s Take on GB:CWK Stock

According to Spark, TipRanks’ AI Analyst, GB:CWK is a Outperform.

Cranswick’s overall stock score of 78 reflects its strong financial performance and positive corporate developments. The strategic growth plans and executive share purchases bolster investor confidence. However, the valuation concerns and technical indicators suggesting potential caution moderate the score.

To see Spark’s full report on GB:CWK stock, click here.

Business Operations and Strategy
Cranswick Director Purchases Shares, Signaling Confidence in Company Growth
Positive
Apr 23, 2025

Cranswick PLC announced a series of transactions involving the purchase of ordinary shares by Rachel Howarth, a Director at the company. These transactions, conducted on the London Stock Exchange, reflect managerial confidence in the company’s performance and strategic direction. The purchases involved a total of 814 shares at varying prices, signaling a positive outlook and potential growth for the company, which could impact stakeholder perceptions and market positioning.

Spark’s Take on GB:CWK Stock

According to Spark, TipRanks’ AI Analyst, GB:CWK is a Outperform.

Cranswick’s overall stock score reflects its strong financial performance, strategic corporate actions, and moderate technical outlook. The company’s robust revenue growth, effective cash flow management, and strategic initiatives such as acquisitions and growth plans position it well for future success. However, caution is advised due to valuation concerns and potential overbought technical indicators.

To see Spark’s full report on GB:CWK stock, click here.

Regulatory Filings and Compliance
Cranswick plc Announces Total Voting Rights Update
Neutral
Apr 2, 2025

Cranswick plc has announced that as of April 1, 2025, the total number of ordinary shares in the company is 54,193,755, each carrying one vote. With no shares held in treasury, the total voting rights amount to 54,193,744, which shareholders can use as a denominator for calculating their interest in the company under the Financial Conduct Authority’s Disclosure and Transparency Rules.

Business Operations and StrategyRegulatory Filings and Compliance
Cranswick PLC Announces Change in Major Holdings
Neutral
Mar 26, 2025

Cranswick PLC, a UK-based company, has announced a change in its major holdings, with JPMorgan Asset Management Holdings Inc. acquiring or disposing of voting rights. The notification indicates that JPMorgan now holds a total of 5.005207% of voting rights in Cranswick, with a combination of direct voting rights attached to shares and financial instruments. This change in holdings could influence Cranswick’s shareholder dynamics and potentially impact its strategic decisions moving forward.

Other
Cranswick CEO Exercises SAYE Options, Acquires Shares
Positive
Mar 26, 2025

Cranswick PLC announced a transaction involving its CEO, Adam Couch, who exercised SAYE options to acquire 591 ordinary shares at a price of 2534 pence each. This transaction, conducted outside a trading venue on March 24, 2025, reflects the CEO’s confidence in the company’s future performance and may positively influence stakeholder perceptions regarding Cranswick’s market positioning and operational stability.

Business Operations and Strategy
Cranswick Director Acquires Shares Under Incentive Plan
Positive
Mar 25, 2025

Cranswick PLC announced that Director Christopher Aldersley acquired ordinary shares under the Cranswick 2024 Buy As You Earn Share Incentive Plan. This transaction, conducted on the London Stock Exchange, reflects the company’s ongoing efforts to align management interests with shareholder value, potentially enhancing stakeholder confidence in the company’s governance and strategic direction.

Business Operations and StrategyFinancial Disclosures
Cranswick Unveils Strategic Growth Plans and Upgraded Financial Targets
Positive
Mar 20, 2025

Cranswick hosted a Capital Markets Day to update on its strategy and announce upgraded medium-term targets. The company plans to secure pig supply, invest in pork processing, and expand poultry capacity, aiming for mid-single-digit organic revenue growth and an increased operating margin of 7.5%. These strategic moves are expected to enhance Cranswick’s competitive advantage and drive growth, reflecting its commitment to disciplined capital allocation and strong customer relationships.

Executive/Board Changes
Cranswick’s Alan Williams Joins Nichols as Non-Executive Director
Neutral
Mar 11, 2025

Cranswick plc has announced that Alan Williams, a Non-Executive Director at the company, has been appointed to the same position at Nichols plc, effective from March 11, 2025. This appointment may strengthen the relationship between the two companies and could potentially impact Cranswick’s strategic positioning within the industry.

Regulatory Filings and Compliance
Cranswick Announces Total Voting Rights Update
Neutral
Mar 5, 2025

Cranswick plc has announced that as of March 4, 2025, the total number of ordinary shares in the company is 54,095,614, with each share carrying one vote. This information is crucial for shareholders to calculate their interests in the company’s share capital under the Financial Conduct Authority’s Disclosure and Transparency Rules.

Business Operations and StrategyRegulatory Filings and Compliance
Cranswick PLC Announces Change in Major Holdings
Neutral
Mar 3, 2025

Cranswick PLC has announced a change in its major holdings, with BlackRock, Inc. adjusting its voting rights to below 5% as of February 27, 2025. This adjustment in holdings may influence Cranswick’s shareholder dynamics, reflecting a strategic move by BlackRock which could impact the company’s market perception and investor relations.

Other
Cranswick Director Acquires Shares Under Incentive Plan
Neutral
Feb 24, 2025

Cranswick plc announced that its Director, Christopher Aldersley, has acquired ordinary shares as ‘Partnership Shares’ under the company’s 2024 Buy As You Earn Share Incentive Plan. This acquisition, part of a regular monthly purchase program, was executed on 21 February 2025 on the London Stock Exchange, reflecting the company’s ongoing efforts to align management interests with shareholder value.

Delistings and Listing Changes
Cranswick Seeks Additional Listing for 200,000 Shares
Neutral
Feb 10, 2025

Cranswick plc has applied for an additional listing on the London Stock Exchange, seeking admission of 200,000 shares under its Savings Related Share Option Scheme (SAYE). These shares will be incorporated into the company’s existing share structure, maintaining equal standing with current ordinary shares, with the listing expected to be effective from February 12, 2025.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.